These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter]. Jastrzebski M Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms and management of proarrhythmia. Roden DM Am J Cardiol; 1998 Aug; 82(4A):49I-57I. PubMed ID: 9737654 [TBL] [Abstract][Full Text] [Related]
10. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
11. Proarrhythmic responses during electrophysiologic testing. Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040 [TBL] [Abstract][Full Text] [Related]
12. Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias. Brembilla-Perrot B; Houriez P; Beurrier D; Claudon O; Terrier de la Chaise A; Louis P Int J Cardiol; 2001 Aug; 80(1):7-15. PubMed ID: 11532541 [TBL] [Abstract][Full Text] [Related]
13. Flecainide-associated bradycardia-dependent torsade de pointes: another potential mechanism of proarrhythmia. Kim HS; Pak HN; Park JS; Kim SS Pacing Clin Electrophysiol; 2013 Mar; 36(3):e84-6. PubMed ID: 21029131 [TBL] [Abstract][Full Text] [Related]
14. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects]. Steinbeck G Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290 [TBL] [Abstract][Full Text] [Related]
15. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors. Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788 [TBL] [Abstract][Full Text] [Related]
16. Atypical proarrhythmia with dofetilide: monomorphic VT and exercise-induced torsade de pointes. Reiffel JA Pacing Clin Electrophysiol; 2005 Aug; 28(8):877-9. PubMed ID: 16105020 [TBL] [Abstract][Full Text] [Related]
17. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370 [TBL] [Abstract][Full Text] [Related]
18. Safety considerations in the pharmacological management of atrial fibrillation. Camm AJ Int J Cardiol; 2008 Jul; 127(3):299-306. PubMed ID: 18191470 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and proarrhythmia of oral sotalol in pediatric patients. Pfammatter JP; Paul T; Lehmann C; Kallfelz HC J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592 [TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and management of proarrhythmias during antiarrhythmic therapy]. Kobayashi Y Nihon Rinsho; 2013 Jan; 71(1):79-85. PubMed ID: 23631176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]